Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Persistence on a stress-challenge task before initiating buprenorphine treatment was associated with successful transition from opioid use to early abstinence.

Strong DR, Brown RA, Sims M, Herman DS, Anderson BJ, Stein MD.

J Addict Med. 2012 Sep;6(3):219-25. doi: 10.1097/ADM.0b013e31825d927f.

2.

Clonidine Maintenance Prolongs Opioid Abstinence and Decouples Stress From Craving in Daily Life: A Randomized Controlled Trial With Ecological Momentary Assessment.

Kowalczyk WJ, Phillips KA, Jobes ML, Kennedy AP, Ghitza UE, Agage DA, Schmittner JP, Epstein DH, Preston KL.

Am J Psychiatry. 2015 Aug 1;172(8):760-7. doi: 10.1176/appi.ajp.2014.14081014.

PMID:
25783757
3.

Preliminary study of buprenorphine and bupropion for opioid-dependent smokers.

Mooney ME, Poling J, Gonzalez G, Gonsai K, Kosten T, Sofuoglu M.

Am J Addict. 2008 Jul-Aug;17(4):287-92. doi: 10.1080/10550490802138814.

4.

Buprenorphine versus methadone in the treatment of opioid dependence: self-reports, urinalysis, and addiction severity index.

Strain EC, Stitzer ML, Liebson IA, Bigelow GE.

J Clin Psychopharmacol. 1996 Feb;16(1):58-67.

PMID:
8834420
5.

Using buprenorphine to facilitate entry into residential therapeutic community rehabilitation.

Collins ED, Horton T, Reinke K, Amass L, Nunes EV.

J Subst Abuse Treat. 2007 Mar;32(2):167-75.

PMID:
17306725
6.

Comparison of pharmacological treatments for opioid-dependent adolescents: a randomized controlled trial.

Marsch LA, Bickel WK, Badger GJ, Stothart ME, Quesnel KJ, Stanger C, Brooklyn J.

Arch Gen Psychiatry. 2005 Oct;62(10):1157-64.

PMID:
16203961
7.

Buprenorphine for human immunodeficiency virus/hepatitis C virus-coinfected patients: does it serve as a bridge to hepatitis C virus therapy?

Taylor LE, Maynard MA, Friedmann PD, Macleod CJ, Rich JD, Flanigan TP, Sylvestre DL.

J Addict Med. 2012 Sep;6(3):179-85. doi: 10.1097/ADM.0b013e318257377f.

8.

Predictors of outcome for short-term medically supervised opioid withdrawal during a randomized, multicenter trial of buprenorphine-naloxone and clonidine in the NIDA clinical trials network drug and alcohol dependence.

Ziedonis DM, Amass L, Steinberg M, Woody G, Krejci J, Annon JJ, Cohen AJ, Waite-O'Brien N, Stine SM, McCarty D, Reid MS, Brown LS Jr, Maslansky R, Winhusen T, Babcock D, Brigham G, Muir J, Orr D, Buchan BJ, Horton T, Ling W.

Drug Alcohol Depend. 2009 Jan 1;99(1-3):28-36. doi: 10.1016/j.drugalcdep.2008.06.016.

9.

Maintenance agonist treatments for opiate-dependent pregnant women.

Minozzi S, Amato L, Bellisario C, Ferri M, Davoli M.

Cochrane Database Syst Rev. 2013 Dec 23;(12):CD006318. doi: 10.1002/14651858.CD006318.pub3. Review.

PMID:
24366859
10.

A pilot study of a distress tolerance treatment for opiate-dependent patients initiating buprenorphine: rationale, methodology, and outcomes.

Brown RA, Bloom EL, Hecht J, Moitra E, Herman DS, Stein MD.

Behav Modif. 2014 Sep;38(5):730-59. doi: 10.1177/0145445514538279.

11.

Prognostic factors in Buprenorphine- versus methadone-maintained patients.

Schottenfeld RS, Pakes JR, Kosten TR.

J Nerv Ment Dis. 1998 Jan;186(1):35-43.

PMID:
9457145
12.

Comparison of behavioral treatment conditions in buprenorphine maintenance.

Ling W, Hillhouse M, Ang A, Jenkins J, Fahey J.

Addiction. 2013 Oct;108(10):1788-98. doi: 10.1111/add.12266.

13.

Bringing buprenorphine-naloxone detoxification to community treatment providers: the NIDA Clinical Trials Network field experience.

Amass L, Ling W, Freese TE, Reiber C, Annon JJ, Cohen AJ, McCarty D, Reid MS, Brown LS, Clark C, Ziedonis DM, Krejci J, Stine S, Winhusen T, Brigham G, Babcock D, Muir JA, Buchan BJ, Horton T.

Am J Addict. 2004;13 Suppl 1:S42-66.

14.

Desipramine in opioid-dependent cocaine abusers maintained on buprenorphine vs methadone.

Oliveto AH, Feingold A, Schottenfeld R, Jatlow P, Kosten TR.

Arch Gen Psychiatry. 1999 Sep;56(9):812-20.

PMID:
12884887
15.

Double successful buprenorphine/naloxone induction to facilitate cardiac transplantation in an iatrogenically opiate-dependent patient.

Rodgman C, Pletsch G.

J Addict Med. 2012 Jun;6(2):177-8. doi: 10.1097/ADM.0b013e3182486e44.

PMID:
22456493
16.
17.

Psychiatric Comorbidity and Substance Use Outcomes in an Office-Based Buprenorphine Program Six Months Following Hurricane Sandy.

Tofighi B, Grossman E, Goldfeld KS, Williams AR, Rotrosen J, Lee JD.

Subst Use Misuse. 2015;50(12):1571-8. doi: 10.3109/10826084.2015.1023455.

PMID:
26623697
18.

Heroin anticraving medications: a systematic review.

Fareed A, Vayalapalli S, Casarella J, Amar R, Drexler K.

Am J Drug Alcohol Abuse. 2010 Nov;36(6):332-41. doi: 10.3109/00952990.2010.505991. Review.

PMID:
20955107
19.

Opioid detoxification with buprenorphine, clonidine, or methadone in hospitalized heroin-dependent patients with HIV infection.

Umbricht A, Hoover DR, Tucker MJ, Leslie JM, Chaisson RE, Preston KL.

Drug Alcohol Depend. 2003 Apr 1;69(3):263-72.

PMID:
12633912
20.

Supplemental Content

Support Center